Durham, NC, United States of America

Hailan Piao


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hailan Piao: Innovator in Antibody Development

Introduction

Hailan Piao is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of antibody development, holding 2 patents that focus on innovative methods for utilizing antibodies in cancer treatment.

Latest Patents

Hailan Piao's latest patents include methods for using antibodies for 3' iso-LM1 and 3', 6'-iso-LD1 tumor gangliosides. High affinity antibodies were developed to target gangliosides expressed on tumor cells. These antibodies can be employed analytically, diagnostically, therapeutically, and theranostically. They are designed to target cytotoxic reagents specifically to tumor cells, thereby minimizing full-body toxicity. Additionally, the antibodies can be used without added cytotoxin and may be detectably labeled or labelable for analytic and diagnostic purposes. The combination of specificity and affinity of these antibodies renders them particularly useful in clinical applications.

Career Highlights

Hailan Piao has worked with prestigious institutions such as Duke University and the US Government as represented by the Secretary of the Army. His work has significantly advanced the understanding and application of antibodies in medical science.

Collaborations

Some of his notable coworkers include Darell D Bigner and Chien-Tsun Kuan. Their collaborative efforts have contributed to the development of innovative solutions in the field of cancer treatment.

Conclusion

Hailan Piao's work in antibody development showcases his commitment to advancing medical science and improving therapeutic options for cancer patients. His innovative patents and collaborations highlight his significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…